← Back to Search

Probiotic

Survival of the Probiotic Lacticaseibacillus Paracasei Strain Shirota (LcS) in the GI Tract of Healthy Adults

N/A
Waitlist Available
Led By Dawn Beckman, MD
Research Sponsored by Yakult U.S.A. Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a special yogurt-like drink with beneficial bacteria to see if they can survive in the gut. Participants will consume the drink, and researchers will check their stool samples to measure the bacteria's survival.

Eligible Conditions
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Live LcS Numbers From Baseline (Day 14) to the End of the Ingestion Period (Day 28).
Secondary study objectives
Change in LcS Number From Baseline (Day 14) to the Mid of Ingestion Period (Day 21).
Change in LcS Numbers From the End of the Ingestion Period (Day 28) and to the End of Follow-up (Day 42).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Test product consumption groupExperimental Treatment1 Intervention
Drink one bottle of Yakult a day

Find a Location

Who is running the clinical trial?

Yakult U.S.A. Inc.Lead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
Biofortis Clinical Research, Inc.Industry Sponsor
11 Previous Clinical Trials
1,015 Total Patients Enrolled
Illinois Institute of TechnologyOTHER
24 Previous Clinical Trials
15,162 Total Patients Enrolled
Dawn Beckman, MDPrincipal InvestigatorBiofortis Clinical Research, Inc.
8 Previous Clinical Trials
460 Total Patients Enrolled
~8 spots leftby Dec 2025